The apparent cooperativity of some GPCRs does not necessarily imply dimerization.

When the binding of one ligand to its receptor is influenced by a second ligand acting on a different receptor, one might assume that the receptors dimerize, enabling allosteric interactions between ligands. This reasoning is frequently used to explain the complex binding curves of ligands of class A G-protein-coupled receptors (GPCRs). Here, we argue that in classical in vitro experiments the lack of GTP makes ligand-binding properties dependent on the available pool of G protein. Under such conditions a 1:1 GPCR-G-protein complex is stabilized, in which the G protein lacks a nucleotide and ligand binding is of high affinity. In vivo, this complex, a key intermediate of G-protein activation, never accumulates because of fast and irreversible GTP binding. In vitro, this complex creates interference in ligand binding when two monomeric GPCRs compete for the same G protein. Interestingly, this competition explains some in vivo effects of orphan GPCRs.

[1]  M. Parmentier,et al.  Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers , 2006, Molecular Pharmacology.

[2]  Martin Heck,et al.  Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit , 2007, Proceedings of the National Academy of Sciences.

[3]  M. Caron,et al.  A mutation of the beta 2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of Gs. , 1990, The Journal of biological chemistry.

[4]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[5]  V. Gurevich,et al.  GPCR monomers and oligomers: it takes all kinds , 2008, Trends in Neurosciences.

[6]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[7]  N. Bennett,et al.  Interactions between photoexcited rhodopsin and GTP-binding protein: kinetic and stoichiometric analyses from light-scattering changes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[8]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[9]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[10]  D. Colquhoun,et al.  Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptors , 1998, British journal of pharmacology.

[11]  J. Harrison,et al.  Chemokine receptor binding and signal transduction in native cells of the central nervous system. , 2003, Methods.

[12]  H. Hamm,et al.  Mapping allosteric connections from the receptor to the nucleotide-binding pocket of heterotrimeric G proteins , 2007, Proceedings of the National Academy of Sciences.

[13]  C. Romano,et al.  Metabotropic Glutamate Receptor 5 Is a Disulfide-linked Dimer* , 1996, The Journal of Biological Chemistry.

[14]  Philippe Delagrange,et al.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization , 2006, The EMBO journal.

[15]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[16]  N. Birdsall Can different receptors interact directly with each other? , 1982, Trends in Neurosciences.

[17]  B. Honig,et al.  Electrostatic and Lipid Anchor Contributions to the Interaction of Transducin with Membranes , 2008, Journal of Biological Chemistry.

[18]  F. Bornancin,et al.  The transitory complex between photoexcited rhodopsin and transducin. Reciprocal interaction between the retinal site in rhodopsin and the nucleotide site in transducin. , 1989, European journal of biochemistry.

[19]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[20]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[21]  N. Bunnett,et al.  Heterologous regulation of trafficking and signaling of G protein-coupled receptors: β-Arrestin-dependent interactions between neurokinin receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. le Maire,et al.  Monomeric G-protein-coupled receptor as a functional unit. , 2005, Biochemistry.

[23]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[24]  H. Khorana,et al.  Rhodopsin mutants that bind but fail to activate transducin. , 1990, Science.

[25]  D. Oprian,et al.  Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.

[26]  T. Ngo,et al.  The receptor-bound "empty pocket" state of the heterotrimeric G-protein alpha-subunit is conformationally dynamic. , 2006, Biochemistry.

[27]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[28]  J. Nelson Structure and Function in Cell Signalling , 2008 .

[29]  H. Loh,et al.  Heterodimerization of μ- and δ-Opioid Receptors Occurs at the Cell Surface Only and Requires Receptor-G Protein Interactions* , 2005, Journal of Biological Chemistry.

[30]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[31]  Vsevolod V Gurevich,et al.  How and why do GPCRs dimerize? , 2008, Trends in pharmacological sciences.

[32]  M. Waelbroeck Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese hamster ovary cell membranes; 1. Mathematical analysis of catalytic G protein activation. , 2001, Molecular pharmacology.

[33]  F. Bruckert,et al.  Kinetic analysis of the activation of transducin by photoexcited rhodopsin. Influence of the lateral diffusion of transducin and competition of guanosine diphosphate and guanosine triphosphate for the nucleotide site. , 1992, Biophysical journal.

[34]  J. Worth Estes,et al.  Trends in pharmacological sciences in 1784 , 1984 .

[35]  M Chabre,et al.  Molecular mechanism of visual transduction. , 1989, European journal of biochemistry.

[36]  L. Stryer,et al.  Flow of information in the light-triggered cyclic nucleotide cascade of vision. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J L Benovic,et al.  Agonist-Receptor-Arrestin, an Alternative Ternary Complex with High Agonist Affinity* , 1997, The Journal of Biological Chemistry.

[38]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Saibil,et al.  Biophysics: is rhodopsin dimeric in native retinal rods? , 2003, Nature.

[40]  Andrea Iaboni,et al.  A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer , 2006, Nature Methods.